Somatostatin receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to (68)Ga-DOTATATE/-TOC uptake

BACKGROUND: The prognosis of patients with progressive meningioma after failure of surgery and radiotherapy is poor. METHODS: We retrospectively evaluated the safety and efficacy of somatostatin-receptor (SSTR)-targeted radionuclide therapy ((177)Lu-DOTATATE [n = 16], (90)Y-DOTATOC [n = 3], or both...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Seystahl, Katharina, Stoecklein, Veit, Schüller, Ulrich, Rushing, Elisabeth, Nicolas, Guillaume, Schäfer, Niklaus, Ilhan, Harun, Pangalu, Athina, Weller, Michael, Tonn, Jörg-Christian, Sommerauer, Michael, Albert, Nathalie L.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2016
Assuntos:
Clinical Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5063513/
https://ncbi.nlm.nih.gov/pubmed/27106404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now060
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados